Cargando…

Administrative Claims Analysis of Asthma-Related Health Care Utilization for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol as Combination Therapy

OBJECTIVES: To compare asthma-related health care resource utilization among a matched cohort of asthma patients using inhaled corticosteroids (ICSs) plus either montelukast (MON) or salmeterol (SAL) as combination therapy for asthma, during a time prior to the availability of fixed-dose combination...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allen-Ramey, Felicia C., Bukstein, Don, Luskin, Allan, Sajjan, Shiva G., Markson, Leona E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438073/ https://www.ncbi.nlm.nih.gov/pubmed/16792437 http://dx.doi.org/10.18553/jmcp.2006.12.4.310

Ejemplares similares

Health Care Utilization Determined From Administrative Claims Analysis for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol
por: Markson, Leona E., et al.
Publicado: (2006)

Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
por: Stanford, Richard H, et al.
Publicado: (2012)

Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids
por: Hodder, Richard, et al.
Publicado: (2007)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
por: Scaparrotta, Alessandra, et al.
Publicado: (2012)

Effects on Resource Utilization of Adding Salmeterol in Combination or Separately to Inhaled Corticosteroids
por: Chan, James, et al.
Publicado: (2007)

Real-life effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid (ICS) in pediatric patients with uncontrolled asthma
por: Bérubé, Denis, et al.
Publicado: (2014)

Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study
por: Bérubé, Denis, et al.
Publicado: (2014)

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial
por: Maltais, François, et al.
Publicado: (2019)

Clinical effect of montelukast sodium combined with inhaled corticosteroids in the treatment of OSAS children
por: Yang, Da-Zhi, et al.
Publicado: (2017)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Comparison of vilanterol, a novel long-acting beta(2) agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
por: Lötvall, Jan, et al.
Publicado: (2014)

Uncovering the regional localization of inhaled salmeterol retention in the lung
por: Bäckström, Erica, et al.
Publicado: (2018)

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis
por: Luskin, Allan T, et al.
Publicado: (2016)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
por: Pavord, Ian, et al.
Publicado: (2007)

Pharmacokinetic characteristics of fluticasone, salmeterol and tiotropium after concurrent inhalation
por: Sunwoo, Jung, et al.
Publicado: (2017)

Effectiveness of Montelukast on asthma control in infants: methodology of a French claims data study
por: Belhassen, Manon, et al.
Publicado: (2015)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Efficacy and safety of salmeterol/fluticasone compared with montelukast alone (or add-on therapy to fluticasone) in the treatment of bronchial asthma in children and adolescents: a systematic review and meta-analysis
por: Zhou, Xiao-Jian, et al.
Publicado: (2021)

Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2
por: Bhattacharyya, Dipankar
Publicado: (2020)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
por: Kim, Min-Hye, et al.
Publicado: (2019)

Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Safety and Efficacy of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler Compared with Fluticasone Propionate/Salmeterol Diskus in Patients with Chronic Obstructive Pulmonary Disease
por: Koser, Andras, et al.
Publicado: (2010)

Inhaled corticosteroids in childhood asthma: the story continues
por: van Aalderen, Wim M. C., et al.
Publicado: (2010)

Extrafine inhaled corticosteroid therapy in the control of asthma
por: Ivancsó, István, et al.
Publicado: (2013)

The use of inhaled corticosteroids in pediatric asthma: update
por: Hossny, Elham, et al.
Publicado: (2016)

Effect of inhaled corticosteroids on systemic inflammation in asthma
por: Karthikeyan, Ramaraju, et al.
Publicado: (2014)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Inhaled corticosteroids: not just for asthma, but for COVID-19?
por: Liew, Felicity, et al.
Publicado: (2022)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023)

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice
por: Singam, Rajeswari, et al.
Publicado: (2006)

Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease
por: Riesenfeld, Erik P, et al.
Publicado: (2010)

Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

Accuracy of the days’ supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids
por: Blais, Lucie, et al.
Publicado: (2014)

A Case of Trigeminal Neuralgia Treated With Combination of Antihistamine, Montelukast, and Corticosteroid Nasal Spray
por: Shahab, Asna, et al.
Publicado: (2020)

Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017)

Inhaled Corticosteroids in Asthma: Promoting or Protecting Against Atherosclerosis?
por: Podgórski, Michał, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u86b5es9r93usqm6toedr2r5eh